Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Bingyu Lin

2PUBLICATIONS

14CO-AUTHORS

Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Apr 05, 2025

Characteristics of second primary malignancies following bispecific antibodies therapy.

Xiaojie Liang, Baiwei Luo, Bingyu Lin

|Nov 17, 2024

Comparison of CAR T-cell and bispecific antibody as third-line or later-line treatments for multiple myeloma: a meta-analysis.

Xiaojie Liang, Yufan Wang, Baiwei Luo

Pageof 1

Frequent Collaborators

2 joint publications

Xiaojie Liang

2 joint publications

Baiwei Luo

2 joint publications

WeiXiang Lu

2 joint publications

Shengyu Tian

2 joint publications

Dan Liu

2 joint publications

Liang Wang

1 joint publications

Yufan Wang

1 joint publications

Jia Guo

1 joint publications

Zihong Cai

1 joint publications

Xinyu Zhou

Frequent Collaborators

2 joint publications

Xiaojie Liang

2 joint publications

Baiwei Luo

2 joint publications

WeiXiang Lu

2 joint publications

Shengyu Tian

Top Related Videos

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on : Feb 21, 2025

See more related videos

Top Related Videos

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on : Feb 21, 2025

See more related videos